These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 8013363)

  • 1. Impact of One-Week Administration of Dihydrotestosterone in Rat Anterior Pituitary Gland.
    Kanasaki H; Tumurbaatar T; Cairang Z; Tumurgan Z; Oride A; Okada H; Kyo S
    Int J Endocrinol; 2022; 2022():9525227. PubMed ID: 36311909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor: a neuroimmune crosstalk mediator for all seasons.
    Skaper SD
    Immunology; 2017 May; 151(1):1-15. PubMed ID: 28112808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells.
    Su Z; Jiang X; Wang C; Liu J; Chen Y; Li Q; Wu J; Zheng W; Zhuge Q; Jin K; Wu Z
    Endocrine; 2012 Dec; 42(3):670-5. PubMed ID: 22684586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cell-cell adhesion in the regulation of prolactin gene expression by extracellular CaCl(2).
    Lail-Trecker MR; Hanrahan CJ; White BA
    Endocrine; 1996 Dec; 5(3):341-9. PubMed ID: 21153086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve growth factor affects Ca2+ currents via the p75 receptor to enhance prolactin mRNA levels in GH3 rat pituitary cells.
    López-Domínguez AM; Espinosa JL; Navarrete A; Avila G; Cota G
    J Physiol; 2006 Jul; 574(Pt 2):349-65. PubMed ID: 16690703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Growth Factors in Normal and Neoplastic Pituitary Tissues.
    Saeger W
    Endocr Pathol; 2000; 11(4):295-300. PubMed ID: 12114754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions.
    Skaper SD
    Mol Neurobiol; 2001; 24(1-3):183-99. PubMed ID: 11831552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hormones, growth factors and their receptors in pituitary tumorigenesis.
    Ezzat S
    Brain Pathol; 2001 Jul; 11(3):356-70. PubMed ID: 11414477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin-producing pituitary adenoma and carcinoma with neuronal components--a metaplastic lesion.
    Scheithauer BW; Horvath E; Kovacs K; Lloyd RV; Stefaneanu L; Buchfelder M; Fahlbusch R; von Werder K; Lyons DF
    Pituitary; 1999 May; 1(3-4):197-205. PubMed ID: 11081198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines.
    Missale C; Codignola A; Sigala S; Finardi A; Paez-Pereda M; Sher E; Spano PF
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5366-71. PubMed ID: 9560282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic and hypophyseal regulation of growth hormone secretion.
    Bluet-Pajot MT; Epelbaum J; Gourdji D; Hammond C; Kordon C
    Cell Mol Neurobiol; 1998 Feb; 18(1):101-23. PubMed ID: 9524732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the low-affinity p75 nerve growth factor receptor in the developing rat pituitary gland.
    Ramaekers D; Proesmans M; Denef C
    Neurochem Res; 1997 Nov; 22(11):1353-7. PubMed ID: 9355107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential responsiveness of late passage C-6 glial cells and advanced passages of astrocytes derived from aged mouse cerebral hemispheres to cytokines and growth factors: glutamine synthetase activity.
    Kazazoglou T; Fleischer-Lambropoulos E; Geladopoulos T; Kentroti S; Stefanis C; Vernadakis A
    Neurochem Res; 1996 May; 21(5):609-14. PubMed ID: 8726970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
    Missale C; Losa M; Boroni F; Giovanelli M; Balsari A; Spano PF
    Br J Cancer; 1995 Dec; 72(6):1397-9. PubMed ID: 8519650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype.
    Missale C; Boroni F; Sigala S; Zanellato A; Dal Toso R; Balsari A; Spano P
    Endocrinology; 1994 Jul; 135(1):290-8. PubMed ID: 8013363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro.
    Missale C; Boroni F; Frassine M; Caruso A; Spano P
    Endocrinology; 1995 Mar; 136(3):1205-13. PubMed ID: 7867574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
    Missale C; Losa M; Sigala S; Balsari A; Giovanelli M; Spano PF
    Mol Endocrinol; 1996 Mar; 10(3):272-85. PubMed ID: 8833656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone and prolactin regulate the expression of nerve growth factor receptors in INS-1 cells.
    Scharfmann R; Atouf F; Tazi A; Czernichow P
    Endocrinology; 1994 Jun; 134(6):2321-8. PubMed ID: 8194458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p75 and Trk: a two-receptor system.
    Chao MV; Hempstead BL
    Trends Neurosci; 1995 Jul; 18(7):321-6. PubMed ID: 7571013
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.